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Neurofibromatosis type 1 (NF1) is a monogenic cancer 
predisposition syndrome that results from germline mu-
tations in the NF1 tumor suppressor gene and predisposes 
affected individuals to develop benign and malignant tu-
mors. One of the significant clinical challenges in manag-
ing children and adults with NF1 is the extreme clinical 
heterogeneity of the disease. In this regard, 15–20% of 
children with NF1 develop low-grade astrocytomas along 
the optic pathway, termed optic pathway gliomas (OPGs; 
Listernick et al., 1994). These tumors, characterized by low 
proliferative indices and infiltration of microglia, lead to 
visual impairment in 30–50% of children with NF1-OPGs. 
Unfortunately, this decline in visual acuity is frequently 
irreversible after successful chemotherapy (Kalin-Hajdu 
et al., 2014). In addition, it is not clear which child with 
an NF1-OPG will experience visual decline and require 
treatment, necessitating that all young children with NF1 
undergo annual ophthalmological evaluations to identify 
those with reduced visual acuity using age-appropriate vi-
sual tests (Listernick et al., 2007). Moreover, these assess-
ments require that preverbal children cooperate and fully 
engage during the examination, which is often challeng-
ing for children with NF1 who harbor comorbid attention 
deficits (Hyman et al., 2005).
To identify potential risk factors for OPG-induced 
visual decline, we recently found that girls with NF1 are 
more likely to lose vision and require treatment than boys 
(Diggs-Andrews et al., 2014b). Importantly, when segmented 
by tumor location within the optic pathway, girls with optic 
nerve gliomas were 5–10 times more likely to experience vi-
sual decline than their male counterparts (Diggs-Andrews et 
al., 2014a; Fisher et al., 2014). Because boys and girls with 
NF1 develop OPGs at relatively similar frequencies, these 
findings indicate that a sexually dimorphic effect may under-
lie OPG-induced vision loss.
In this study, we leveraged an Nf1 genetically engi-
neered mouse strain that similarly exhibits sexually dimorphic 
differences in optic glioma–induced visual acuity impairment 
to define the molecular and cellular basis for these effects 
(Diggs-Andrews et al., 2014b). We demonstrate, for the first 
time, that female gonadal sex hormones are responsible for 
increased retinal ganglion cell (RGC) loss and retinal nerve 
fiber layer (RNFL) thinning secondary to murine optic gli-
oma, which reflects estrogen receptor activation of tumor-as-
sociated microglia. Together, these findings establish that 
children with neurofibromatosis type 1 (nF1) develop low-grade brain tumors throughout the optic pathway. nearly 50% of 
children with optic pathway gliomas (oPGs) experience visual impairment, and few regain their vision after chemotherapy. 
recent studies have revealed that girls with optic nerve gliomas are five times more likely to lose vision and require treatment 
than boys. to determine the mechanism underlying this sexually dimorphic difference in clinical outcome, we leveraged nf1 
optic glioma (nf1-oPG) mice. We demonstrate that female nf1-oPG mice exhibit greater retinal ganglion cell (rGc) loss and 
only females have retinal nerve fiber layer (rnFL) thinning, despite mice of both sexes harboring tumors of identical volumes 
and proliferation. Female gonadal sex hormones are responsible for this sexual dimorphism, as ovariectomy, but not castration, 
of nf1-oPG mice normalizes rGc survival and rnFL thickness. In addition, female nf1-oPG mice have threefold more microg-
lia than their male counterparts, and minocycline inhibition of microglia corrects the retinal pathology. Moreover, pharmaco-
logic inhibition of microglial estrogen receptor-β (Erβ) function corrects the retinal abnormalities in female nf1-oPG mice. 
collectively, these studies establish that female gonadal sex hormones underlie the sexual dimorphic differences in nf1 optic 
glioma–induced retinal dysfunction by operating at the level of tumor-associated microglial activation.
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female gonadal sex hormones act as microglial activators in 
the pathogenesis of NF1-OPG visual decline.
rEsuLts and dIscussIon
rGc death and rnFL loss are sexually 
dimorphic in nf1-oPG mice
To define the molecular and cellular basis underlying the 
observed sexually dimorphic visual decline in children with 
NF1-OPG, we used a credentialed Nf1-OPG genetically en-
gineered mouse strain (Bajenaru et al., 2003), in which optic 
nerve and chiasmal gliomas form by 3 mo of age, and mice 
exhibit decreased visual acuity in a sexually dimorphic man-
ner by 6 mo of age (Diggs-Andrews et al., 2014b). A 56% 
reduction in RGC numbers (% Brn3a+ cells) was observed 
in female Nf1-OPG mice relative to controls (Nf1flox/flox mice 
[FF]), with only minor changes in their male counterparts 
(Fig.  1 A). The reduction in RGC number was caused by 
increased apoptosis, as indicated by a 10-fold increase in the 
percentage of cleaved caspase-3+ cells (Fig. 1 B). The selec-
tive death of RGCs (Fig.  1  C) reflects a predominance of 
Nf1 protein (neurofibromin) expression in RGCs within the 
retina (Fig. 1 D). Consistent with RGC death resulting from 
axonal injury, increased phospho-neurofilament heavy chain 
(pNF-H) immunostaining, a marker of axonal injury (Parrilla- 
Reverter et al., 2009), was observed in the optic nerves of 
female Nf1-OPG mice (Fig. 1 E).
Figure 1. retinal dysfunction is sexually dimorphic in nf1-oPG mice. (A) The percentage of Brn3a+ RGCs was decreased in female Nf1-OPG mice 
(mean, 56.13 ± 13.11% SD; n = 7 mice) compared with FF controls (103.6 ± 8.6%; n = 7 mice), and to a lesser degree in their male counterparts (FF males, 
100 ± 10.91%; n = 7 mice; Nf1-OPG males, 79.01 ± 11.6%; n = 7 mice). (B) Cleaved caspase-3+ cells were increased in female Nf1-OPG mice (15.52 ± 4.52%; 
n = 6 mice) compared with FF controls (1.45 ± 1.09%; n = 6 mice), but were less elevated in male Nf1-OPG mice (0.822 ± 1.29%; n = 8 mice) relative to FF 
controls (6.451 ± 3.72%; n = 6 mice). (C) Double-labeled Brn3a+ (red) and TUN EL+ cells (green) were detected in female Nf1-OPG mice. (D) Neurofibromin 
(green) was primarily expressed in Brn3a+ (red) RGCs in WT mice. (E) pNF-H immunostaining was detected in the optic nerves of female Nf1-OPG mice, but 
not Nf1-OPG males or controls. (F) IPL-GCL layer thickness showed no differences in males (FF, 54.41 ± 6.3 µm; n = 6 mice; OPG, 51.23 ± 6.67 µm; n = 6 
mice), whereas thinning was found in Nf1-OPG females (39.54 ± 3.55 µm; n = 7 mice) compared with controls (FF, 60.1 ± 5.96 µm; n = 6 mice). (G) SMI-32 
staining (RNFL thickness) revealed thinning in female Nf1-OPG retinae (4.82 ± 0.64 µm; n = 6 mice) relative to controls (10.14 ± 1.99 µm; n = 6 mice). No 
differences were seen in males (FF, 10.37 ± 1.5 µm; n = 6 mice; OPG, 10.22 ± 3.46 µm; n = 6 mice). (H) Decreased SMI-32 staining was observed in female 
Nf1-OPG retinal flatmounts (left) and by immunoblotting (right). Data in A, B, F, and G were analyzed using a one-way ANO VA (Kruskal-Wallis test) with a 
Dunn’s multiple comparison post-test. Similar results were obtained in a second independent experiment containing six mice per group. Bars, 100 µm. *, P < 
0.05; **, P < 0.01; ***, P < 0.001.
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In children with NF1, optical coherence tomography 
(OCT) is often used to monitor visual dysfunction secondary 
to OPG (Fisher et al., 2012). OCT measures the thickness of 
the RNFL (composed of RGC axons) and the inner plexi-
form layer/ganglion cell layer (IPL-GCL; Avery et al., 2011; 
Gu et al., 2014). Similar to the sexually dimorphic RGC 
effects, IPL-GCL and RNFL thicknesses were reduced by 
34.2% (Fig.  1 F) and 52% (Fig.  1 G) in female Nf1-OPG 
mice, respectively, compared with controls. No significant 
differences were found between male Nf1-OPG mice and 
controls, as further demonstrated using retinal flat-mount 
preparations (SMI-32 immunostaining) and Western blotting 
(Fig. 1 H). Together, these observations establish that female 
Nf1-OPG mice exhibit greater tumor-induced axonal injury, 
leading to RGC loss and RNFL/IPL-GCL thinning.
Female gonadal sex hormones underlie the sexually 
dimorphic differences in nf1-oPG–induced axonal damage 
and retinal dysfunction
Using the AOS strategy (Arnold, 2014), we first analyzed go-
nadal steroid hormones (estradiol, testosterone) as responsible 
etiologies. Although gonadal sex hormones are usually con-
sidered to function during or after puberty, there is an abun-
dance of experimental data supporting critical roles for these 
hormones in brain neurons during fetal and early perinatal 
life in several vertebrate species (Bondesson et al., 2015). 4-vi-
nylcyclohexene diepoxide (VCD) was initially used to chem-
ically ablate ovarian function (Kappeler and Hoyer, 2012), 
which reduced RGC death (%TUN EL+ cells) by 2.97-fold 
(Fig.  2  A) and increased RGC numbers (%Brn3a+ cells) 
from 50 to 73% of WT levels (Fig. 1 A). Because VCD can 
have off-target effects, we performed surgical ovariectomies 
(OVX) of female Nf1-OPG mice, castration (Cast) of male 
Nf1-OPG mice, and respective sham surgeries at 6 wk of age. 
After male gonadectomy, serum testosterone levels decreased 
by 8.3-fold (Fig.  2  B); however, there was no change in 
RGC death (%TUN EL+ cells and %Brn3a+ cells) or RNFL 
thinning (Fig. 2 C). These results demonstrate that male go-
nadal sex hormones do not provide a neuroprotective effect 
for RGC survival in the setting of optic glioma. In contrast, 
OVX resulted in a 7.2-fold decrease in serum 17-β estradiol 
levels (Fig. 2 B) and a 4.3-fold reduction in the percentage of 
TUN EL+ cells, increasing the percentage of Brn3a+ cells from 
∼50 to ∼77% and RNFL thickness from ∼46 to ∼100% of 
WT levels, respectively (Fig. 2 D).
Because girls and boys with NF1 are equally likely to 
develop an optic glioma (Diggs-Andrews et al., 2014b), we 
examined the optic gliomas in male and female Nf1-OPG 
mice. No differences were observed between male and fe-
male Nf1-OPG mice with respect to tumor penetrance, optic 
nerve volumes, proliferation, or astrocyte number (Fig. 2 E); 
however, OVX significantly affected glioma maintenance. 
Castrated males showed no differences in optic nerve vol-
umes or proliferation (Fig. 2 F) or pNF-H immunostaining 
(Fig. 2 F), but OVX Nf1-OPG females exhibited a 42% de-
crease in optic nerve volume, a 70% decrease in proliferation, 
and reduced optic nerve pNF-H staining (Fig. 2 G). Collec-
tively, these findings establish that gonadal sex hormones are 
critical for optic glioma growth, axonal damage, and retinal 
pathology in female Nf1-OPG mice.
optic glioma–associated microglia activation underlie 
axonal damage and retinal dysfunction in nf1-oPG mice
Microglia comprise 30–50% of the cells in human NF1-asso-
ciated and sporadic low-grade gliomas (Simmons et al., 2011). 
Although their murine counterparts have slightly lower per-
centages of microglia (10–15% Iba1+ cells), these Nf1 mouse 
optic glioma–associated monocytes (Daginakatte and Gut-
mann, 2007) and their secreted chemokines (Ccl5; Solga et 
al., 2015) are critical for tumor maintenance. Based on these 
findings, we focused on microglia as potential cellular media-
tors of the observed sexually dimorphic effects.
First, we observed that female Nf1-OPG mice harbored 
2.8-fold more optic glioma–associated microglia compared 
with their male counterparts (Fig.  3  A). Second, microglia 
numbers were also elevated in female, but not male, Nf1+/− 
optic nerves relative to their WT counterparts, even in 
the absence of an optic glioma (Fig. 3 B). Third, there was 
greater microglial activation (Daginakatte et al., 2008) in 
female Nf1-OPG mice, as indicated by a 3.2-fold increase 
in phospho-JNK+ cells, relative to their male counterparts. 
However, Ccl5 expression did not differ between male and 
female Nf1-OPG mice, suggesting that this chemokine 
functions to support tumor growth in both males and fe-
males (unpublished data).
Because the proliferation and volumes of male and fe-
male murine optic gliomas were equivalent, we postulated 
that the relative increase in microglia and microglial activation 
might underlie the sexually dimorphic differences in optic 
glioma–induced retinal dysfunction. As such, previous studies 
have demonstrated that microglia can increase neuronal cell 
death and axonal injury in other experimental nervous system 
diseases (Neher et al., 2011; Schneider et al., 2015). Addition-
ally, gonadal sex hormones, such as estrogen, have been previ-
ously implicated in brain microglia function (Tapia-Gonzalez 
et al., 2008; Saijo et al., 2011). To determine whether gonad-
ectomy changes microglia content, we examined the percent-
age of Iba1+ cells after gonadectomy. Although castration had 
no effect on microglial content, there was an approximately 
twofold decrease in the percentage of Iba1+ cells after OVX, 
reducing microglia numbers to WT levels (Fig. 3 C). Addi-
tionally, the percentage of amoeboid-shaped (activated) mi-
croglia was reduced from 70 to 32% after OVX (Fig. 3 D).
To determine whether inhibition of microglia function 
could attenuate retinal dysfunction and axonal damage, fe-
male Nf1-OPG mice were treated with minocycline, a com-
monly used microglial pharmacologic inhibitor (Tikka et 
al., 2001). After treatment, there was a 1.7-fold decrease in 
the percentage of Iba1+ cells (Fig.  3  E), decreased pNF-H 
immunostaining (Fig.  3  E), and a 3.9-fold decrease in the 
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Figure 2. depletion of female gonadal sex hormones rescues tumor growth and rGc death in nf1-oPG females. (A) VCD treatment decreased 
TUN EL+ cells in the RGC layer (Vehicle, 14.8 ± 2.7%; VCD, 4.9 ± 2.9; n = 6 mice) and increased the percentage of Brn3a+ RGCs in FMC mice (Vehicle, 49.3 
± 10.8%; VCD, 73.1 ± 7.5; n = 7 mice/group). (B) Serum testosterone levels decreased after castration (Cast) of male Nf1-OPG mice (Sham, 1.19 ±0.14 ng/
ml; Cast, 0.14 ± 0.05 ng/ml; n = 5 mice/group). Serum 17-β estradiol levels decreased after OVX of female Nf1-OPG mice (Sham, 9.33 ± 2.1 pmol/ml; OVX, 
1.29 ± 0.88 pmol/ml; n = 7 mice/group). (C) Castration did not change retinal apoptosis (%TUN EL+ cells; Sham, 6.53 ± 1.83; Cast, 6.25 ± 2.16; n = 7 mice), 
RGC loss (%Brn3a+ cells; Sham, 83.78 ± 6.7; Cast, 86.21 ± 8.1; n = 7 mice/group), or RNFL thickness (SMI-32 staining; Sham, 10.14 ± 2.35 µm; Cast, 10.77 
± 2.2 µm; n = 7 mice/group). (D) OVX reduced RGC death (%TUN EL+ cells; Sham, 13.19 ± 4.0; OVX, 2.98 ± 1.2; n = 7 mice/group), RGC loss (%Brn3a; Sham, 
49.56 ± 13.9; OVX, 77.42 ± 11.7; n = 7 mice/group), and RNFL thinning (SMI-32 staining; Sham, 5.51 ± 1.6 µm; OVX, 12.2 ± 1.97 µm; n = 7 mice/group). 
(E) No differences in optic nerve volumes (Male, 0.087 ± 0.003 mm3; Female, 0.095 ± 0.011 mm3; n = 17 mice/group), %Ki67+ cells (Male, 3.95 ± 2.81%; 
Female 3.76 ± 0.81%; n = 9 mice/group), or percentage of S100β+ cells (Male, 65.35 ± 5.01%; Female, 59.81 ± 5.1%; n = 5 mice/group) were found in the 
optic nerves of male compared with female Nf1-OPG mice. (F) Optic nerve volume measurements (top; Sham, 0.084 ± 0.02 mm3; Cast, 0.092 ± 0.02 mm3; 
n = 6 mice/group), %Ki67+ cells (middle; Sham, 3.08 ± 1.1%; Cast, 3.19 ± 2.08%; n = 6 mice/group), and pNF-H staining (bottom) within the optic nerve were 
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percentage of TUN EL+ cells (Fig. 3 F). In addition, the per-
centage of Brn3a+ cells increased from ∼40 to ∼70%, and 
RNFL thickness increased from ∼38 to ∼97% of WT levels, 
respectively (Fig. 3 F), thus establishing an essential role for 
microglia in mediating glioma maintenance (Daginakatte and 
Gutmann, 2007), as well as axonal damage, RGC death, and 
RNFL thinning, in response to murine optic glioma.
Estrogen acts through Erβ to activate optic nerve 
microglia in female nf1-oPG mice
Estrogen can function either through its canonical (ERα and 
ERβ) receptors (Green et al., 1986; Kuiper et al., 1996) or 
via G-protein–coupled receptors (GPR30; Revankar et al., 
2005). We first excluded GPR30 as a possible mediator using 
a selective GRP30 antagonist, G-15 (Dennis et al., 2009), 
and found that treatment of female Nf1-OPG mice did not 
change RGC apoptosis (unpublished data). Next, we focused 
on the ERα and ERβ receptors, which are both expressed 
in the optic nerve. However, ERβ is exclusively expressed in 
microglia (Wu et al., 2013), as confirmed herein using dou-
ble-labeling immunohistochemistry (Fig. 4 A).
Two inflammatory cytokines (IL-1β and IL-6) impli-
cated in neuronal apoptosis (Azevedo et al., 2013; Guadagno 
et al., 2015) are known to be regulated by ERβ engagement 
in brain microglia (Saijo et al., 2011). For this reason, we ex-
amined IL-1β (Fig. 4 B) and IL-6 (Fig. 4 C) levels, which 
were both elevated in the optic nerves of female, but not male, 
Nf1-OPG mice. To determine whether microglial activa-
tion, cytokine production, and subsequent neuronal damage 
were driven by ERβ activation, female Nf1-OPG mice were 
treated for 6 wk with 4-[2-phenyl-5,7-bis(trifluoromethyl)
pyrazolo[1,5-a]-pyrimidin-3-yl]phenol (PHT PP), a selective 
ERβ antagonist (Compton et al., 2004). After treatment, there 
was a 2.4-fold decrease in the percentage of Iba1+ cells, 20% 
decrease in optic nerve volumes, and 7.5-fold decrease in pro-
liferation (%Ki67+ cells), as well as reduced pNF-H staining 
and IL-1β/IL-6 expression (Fig. 4 D). The observed positive 
regulation of IL-1β in microglia by estradiol contrasts with 
other studies demonstrating negative regulation (Saijo et 
al., 2011; Zhao et al., 2016), which we postulate may reflect 
different disease contexts (experimental allergic encephalo-
myelitis versus neoplasia) and/or divergent mechanisms of 
estradiol signaling (GPR30 versus ERβ engagement).
Consistent with a critical role for microglia ERβ func-
tion in mediating neuronal cell death, ERβ inhibition de-
creased RGC apoptosis (%TUN EL+ cells) to WT levels, 
increased the percentage of RGC number to 81% of WT 
levels, and increased the RNFL thickness from ∼44 to 100% 
of WT levels in Nf1-OPG mice (Fig.  4  E). Although it is 
not possible to completely separate the effects of ERβ acti-
vation on microglia-induced tumor growth from its effects 
on neuronal injury, these findings support a model in which 
microglia are critical drivers of glioma formation and main-
tenance in both male and female Nf1 mice, likely through 
the actions of nonsexually dimorphic stromal factors (e.g., 
CCL5), whereas the tumor microenvironment created by 
ERβ-mediated release of neurotoxins (e.g., IL-1β and other 
inflammatory cytokines) facilitates the axonal injury, RGC 
death, RNFL thinning, and visual impairment observed 
in female Nf1-OPG mice.
In summary, these studies reveal critical roles for both 
estrogen and microglia in the neuronal injury response to 
optic glioma; however, the precise mechanism by which 
microglia create a neurotoxic environment, independent of 
tumor size, remains to be elucidated. Current studies are 
under way to examine specific inflammatory mediators 
(e.g., IL-1β and IL-6), as well as to define the transcrip-
tional program of microglia in response to ERβ activation 
in the context of murine Nf1-OPG. The finding that fe-
male susceptibility to axonal injury, retinal pathology, and 
vision loss in the setting of optic glioma reflects estrogen 
activation of microglia represents one of the first demon-
strations of sexually dimorphic differences in human disease. 
As the underlying molecular and cellular etiologies become 
clearer, potential neuroprotective strategies for reversing vi-
sual decline might emerge.
MatErIaLs and MEthods
Mice
Nf1flox/mut;GFAP-Cre mice (Nf1+/− mice with somatic Nf1 
loss in neuroglial progenitor cells) were generated and main-
tained on a C57BL/6 background (Bajenaru et al., 2003). 
Analysis of mice was performed at 3 mo of age using in-
dependently generated cohorts. All animals were used in 
accordance with protocols approved by the animal studies 
committee at Washington University.
Pharmacological treatments
4-vinylcycohexene diepoxide (VCD; 160 mg/kg; Sig-
ma-Aldrich) diluted in corn oil (vehicle) was adminis-
tered by i.p. injection for 20 consecutive d. Minocycline 
hydrochloride (50 mg/kg; Sigma-Aldrich) dissolved in 
sterile PBS was administered by i.p. injection for 5 d/
week (2 wk), and controls received PBS injections. The 
selective ERβ antagonist PHT PP (4 mg/kg body weight; 
Sigma-Aldrich) was dissolved in corn oil and administered 
i.p. for 5 d/week (6 wk to 3 mo of age). Controls received 
i.p. corn oil injections.
unchanged after castration. (G) Optic nerve volumes (top; Sham, 0.085 ± 0.006 mm3; OVX, 0.049 ± 0.004 mm3; n = 5 mice/group) and %Ki67+ cells (middle; 
Sham, 3.2 ± 0.64%; OVX, 0.96 ± 0.34%; n = 5 mice/group) were decreased after OVX. Axonal damage (pNF-H, bottom) was decreased after OVX of Nf1-OPG 
females relative to sham controls. Data in A–G were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results were obtained in a 
second independent experiment containing six mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001; n.s., not significant.
 o
n






Estrogen increases microglia-mediated retinal damage | Toonen et al.22
Western blotting
Retinae were microdissected and tissues were sonicated in 1% 
NP-40 buffer supplemented with protease and phosphatase 
inhibitors. Protein concentrations were determined using a 
BCA protein assay kit (Thermo Fisher Scientific), and West-
ern blotting was performed as previously described using 
SMI-32 (BioLegend; 1:500 dilution; Daginakatte and Gut-
mann, 2007) antibodies and developed using chemilumines-
cence detection on a ChemiDoc-It Imaging System (UVP).
retinal flat-mount staining
Eyes were fixed with 4% paraformaldehyde for 1 h and washed 
with PBS, and retinae were microdissected using 4 small inci-
sions. Retinae were post-fixed in methanol and stored over-
Figure 3. Microglia causes axonal damage and rGc death in female nf1-oPG mice. (A) Optic nerves of female Nf1-OPG mice contained increased 
%Iba1+ cells (Male, 5.8 ± 2.11%; Female, 12.96 ± 5.06%; n = 10 mice/group) and p-JNK+ cells (Male, 4.16 ± 3.2%; Female, 13.5 ± 4.7%; n = 8 mice/group). 
(B) Immunostaining revealed increased Iba1+ cells in Nf1+/− females compared with WT controls (WT, 6.7 ± 1.1%; Nf1+/−, 9.9 ± 1.1%; n = 6 mice/group); 
however, no differences were observed in males (WT, 6.9 ± 1.7%; Nf1+/−, 7.4 ± 1.3%). (C) The %Iba1+ cells (top; Sham, 6.21 ± 2.05%; Cast, 6.1 ± 2.26%; n = 
8 mice/group) did not differ between castrated Nf1-OPG males and sham controls. In contrast, the %Iba1+ cells (bottom; Sham, 10.7 ± 4.84%; OVX, 5.83 ± 
1.55%; n = 11 mice/group) were decreased after OVX in Nf1-OPG females compared with sham controls. Ramified microglia constitute 19.8% of the total 
microglia in sham Nf1-OPG female mice and 53.6% of the total microglia after OVX, whereas amoeboid or activated microglia are constituted 70% of the 
total microglia in sham Nf1-OPG optic nerves and 32% in OVX optic nerves (n = 6 mice/group). (D) Minocycline-treated female Nf1-OPG mice exhibited a 
decreased %Iba1+ cells in the optic nerve (Control, 11.12 ± 1.71%; minocycline, 6.61 ± 2.3%; n = 8 mice/group) and axonal damage (pNF-H immunostaining). 
(E) After minocycline treatment, there was a reduction in the %TUN EL+ cells (Control, 14.75 ± 1.1; minocycline, 3.75 ± 1.82; n = 6 mice/group), an increase in 
the %Brn3a+ cells (Control, 39.79 ± 1.69%; minocycline, 70.42 ± 2.66%; n = 6 mice/group), and increased the RNFL thickness (SMI-32 staining; Control, 4.51 
± 1.1 µm; minocycline, 9.2 ± 1.9 µm; n = 8 mice/group). Data in A–E were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results 
were obtained in a second independent experiment containing five mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n.s., not significant.
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Figure 4. Estrogen acts through Erβ to activate optic nerve microglia in female nf1-oPG mice. (A) Immunostaining for Iba1+, ERα+ double-labeled 
cells in the optic nerve (bottom, arrows). Immunostaining was performed for Il-1β (B) and Il-6 (C) in the optic nerves of FF male and female mice, as well 
as in Nf1-OPG male and female mice. (D) Optic nerves volumes (Control, 0.089 ± 0.02 mm3; PHT PP, 0.071 ± 0.01 mm3; n = 7 mice/group) and %Ki67+ cells 
(Control, 4.75 ± 2.2%; PHT PP, 0.64 ± 0.59%; n = 6 mice/group) were decreased after PHT PP treatment (top). Microglia numbers (%Iba1+ cells, Control, 12.33 
± 5.9; PHT PP, 5.44 ± 1.3, n = 8 mice/group), axonal injury (pNF-H), and IL-1β/IL-6 levels were decreased after treatment with PHT PP. (E) PHT PP treatment 
reduced the %TUN EL+ cells (Control, 10.7 ± 0.78%; PHT PP, 1.95 ± 0.56%; n = 6 mice/group), increased the %Brn3a+ cells (Control, 49.58 ± 2.69%; PHT 
PP, 81.7 ± 4.9%; n = 6 mice/group), and increased the RNFL thickness (SMI-32 staining; Control, 4.5 ± 0.4 µm; PHT PP, 10.5 ± 0.5 µm; n = 6 mice/group). 
Data in D and E were analyzed using a nonparametric Student’s t test (Mann-Whitney). Similar results were obtained in a second independent experiment 
containing five mice per group. Bars, 100 µm. *, P < 0.05; **, P < 0.01; ***, P < 0.001. n.s., not significant.
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night before incubation with SMI-32 antibody overnight 
(1:250) and immunofluorescent microscope imaging.
castration and oVX
After anesthesia, 6-wk-old male mice were castrated by vas 
deferens cauterization using sterile surgical instruments in 
the Mouse Genetics Core at Washington University. Simi-
larly, 6-wk-old female mice were surgically OVX and their 
fallopian tubes were ligated. Afterward, the skin was sutured 
and topical analgesics lidocaine ointment or bupivacaine 
were applied. Sham controls underwent identical proce-
dures minus the gonadectomy.
Immunohistochemistry
After perfusion with Ringer’s solution containing 0.1% lido-
caine, 0.25% heparin, and 4% paraformaldehyde, optic nerves 
and eyeballs were post-fixed in 4% paraformaldehyde over-
night. Tissues were embedded in paraffin and sectioned at 
5 µm for immunostaining with the antibodies the following 
antibodies: Brn3a (1:500; Santa Cruz Biotechnology, Inc.), 
cleaved caspase-3 (1:250; R&D Biosystems), estrogen recep-
tor α (1:200; Abcam), estrogen receptor β (1:200; Abcam), 
Iba1 (1:200; Novus Biologicals), Iba1 (1:1,000; Wako), IL-1β 
(1:200; Abcam), IL-6 (1:200; Santa Cruz Biotechnology, Inc.), 
Ki67 (1:500; BD), Neurofibromin (1:200; Santa Cruz Bio-
technology, Inc.), pNF-H (1:1,000; Abcam), pSAPK-JNK 
(1:50; Cell Signaling Technology), SMI-32 (1:500; BioLeg-
end). Biotinylated secondary antibodies (Vector Labs) were 
used for immunohistochemistry and developed using the 
Vectastain ABC kit. Alexa Fluor (Thermo Fisher Scientific) 
secondary antibodies were used for immunofluorescent stain-
ing. Terminal deoxynucleotide transferase–mediated dUTP 
nick ended (TUN EL) labeling (Roche) was performed as per 
the manufacturer’s instructions.
optic nerve measurements
Microdissected optic nerves were fixed in 4% paraformal-
dehyde overnight and then photographed, and diameters 
were measured beginning at the chiasm (and subsequently 
∼150, ∼300, and ∼450 µm anterior to the chiasm) to 
generate optic nerve volumes as previously reported 
(Hegedus et al., 2008).
retinal analyses
RNFL measurements were performed using ImageJ (Na-
tional Institutes of Health) software on sections through 
the plain including pupil and optic nerves. Images were 
taken at 20× fields from 0 to 300 µm proximal to the 
optic nerve head. Repeated measurements of stained axons 
(SMI-32+staining) were recorded and averaged for each area 
corresponding to each genotype.
serum estradiol and testosterone assay
Serum was separated from whole blood after centrifuga-
tion and analyzed using 17β-Estradiol (Enzo Life Sciences) 
and Testosterone (Enzo Life Sciences) ELI SA kits as per the 
manufacturer’s protocol.
statistical analysis
Statistical analysis was performed using Prism 5.0 software 
(GraphPad). Analyses involving only two groups were per-
formed using nonparametric Student’s t test (Mann-Whit-
ney) and four groups were compared using a nonparametric 
one-way ANO VA (Kruskal-Wallis test) using Dunn’s multiple 
comparison posttest. Statistical significance predetermined to 
be P < 0.05 for all statistical tests.
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